BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19771814)

  • 21. Chronic hepatitis B: update 2009.
    Lok AS; McMahon BJ
    Hepatology; 2009 Sep; 50(3):661-2. PubMed ID: 19714720
    [No Abstract]   [Full Text] [Related]  

  • 22. Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
    Matthews GV; Dore GJ
    AIDS; 2007 Mar; 21(6):777-8. PubMed ID: 17413705
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
    Psevdos G; Gonzalez E; Sharp V
    AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV and hep B drug trial enrolling.
    Vazquez E
    Posit Aware; 1997; 8(5):17. PubMed ID: 11364634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic hepatitis B. Tenofovir--the right choice from the beginning].
    MMW Fortschr Med; 2008 May; 150(21):42-3. PubMed ID: 18575255
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of tenofovir in the prevention of HIV infections.
    De Clercq E
    AIDS; 2006 Oct; 20(15):1990-1. PubMed ID: 16988528
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse effects of tenofovir use in HIV-infected pregnant women and their infants.
    Nurutdinova D; Onen NF; Hayes E; Mondy K; Overton ET
    Ann Pharmacother; 2008 Nov; 42(11):1581-5. PubMed ID: 18957630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Navigating the maze of hepatitis B treatments.
    Lok AS
    Gastroenterology; 2007 Apr; 132(4):1586-94. PubMed ID: 17408643
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.
    Jaafar A; Séronie-Vivien S; Malard L; Massip P; Chatelut E; Tack I
    AIDS; 2009 Jan; 23(2):257-9. PubMed ID: 19098496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B infection in an HIV-positive man treated with tenofovir: a case of re-infection or reactivation?
    Richardson D; Lamba H
    Int J STD AIDS; 2004 Mar; 15(3):204-5. PubMed ID: 15038871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B and adefovir depivoxil.
    AIDS Patient Care STDS; 1997 Apr; 11(2):103. PubMed ID: 11361755
    [No Abstract]   [Full Text] [Related]  

  • 32. Surrogate end-points for treatment trials of hepatitis B virus.
    Griffiths PD
    Rev Med Virol; 2010 Jul; 20(4):199-201. PubMed ID: 20586100
    [No Abstract]   [Full Text] [Related]  

  • 33. Stakeholder consultation to address issues related to tenofovir prophylactic research.
    Halima Y; Collins C
    IAPAC Mon; 2005 Jun; 11(6):166-9. PubMed ID: 16276586
    [No Abstract]   [Full Text] [Related]  

  • 34. Tenofovir works as pre-exposure prophylaxis against HIV, two studies confirm.
    Roehr B
    BMJ; 2011 Jul; 343():d4540. PubMed ID: 21765115
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute renal failure after initiation of tenofovir disoproxil fumarate.
    Hynes P; Urbina A; McMeeking A; Barisoni L; Rabenou R
    Ren Fail; 2007; 29(8):1063-6. PubMed ID: 18067059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment on: suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir.
    Anderson PL; Kakuda TN
    J Antimicrob Chemother; 2006 Jul; 58(1):220-1. PubMed ID: 16717052
    [No Abstract]   [Full Text] [Related]  

  • 37. Tenofovir and renal toxicity.
    AIDS Patient Care STDS; 2004 Oct; 18(10):615-6. PubMed ID: 15633256
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome.
    Schaaf B; Aries SP; Kramme E; Steinhoff J; Dalhoff K
    Clin Infect Dis; 2003 Aug; 37(3):e41-3. PubMed ID: 12884188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible allergic cross-reaction to didanosine and tenofovir in an HIV-1-infected woman.
    Ripamonti D; Maggiolo F; Suter F
    AIDS; 2007 May; 21(8):1059-60. PubMed ID: 17457107
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.